Your browser doesn't support javascript.
loading
Multiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations.
Garcia, Joseph H; Akins, Erin A; Jain, Saket; Wolf, Kayla J; Zhang, Jason; Choudhary, Nikita; Lad, Meeki; Shukla, Poojan; Rios, Jennifer; Seo, Kyounghee; Gill, Sabraj A; Carson, William H; Carette, Luis R; Zheng, Allison C; Raleigh, David R; Kumar, Sanjay; Aghi, Manish K.
Afiliação
  • Garcia JH; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Akins EA; Department of Bioengineering, UC Berkeley, Berkeley, California, USA.
  • Jain S; Graduate Program in Bioengineering, UC Berkeley-UCSF, San Francisco, California, USA.
  • Wolf KJ; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Zhang J; Department of Bioengineering, UC Berkeley, Berkeley, California, USA.
  • Choudhary N; Department of Bioengineering, UC Berkeley, Berkeley, California, USA.
  • Lad M; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Shukla P; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Rios J; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Seo K; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Gill SA; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Carson WH; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Carette LR; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Zheng AC; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Raleigh DR; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Kumar S; Department of Neurosurgery, UCSF, San Francisco, California, USA.
  • Aghi MK; Department of Bioengineering, UC Berkeley, Berkeley, California, USA.
J Clin Invest ; 134(3)2023 Nov 16.
Article em En | MEDLINE | ID: mdl-37971886
While the poor prognosis of glioblastoma arises from the invasion of a subset of tumor cells, little is known of the metabolic alterations within these cells that fuel invasion. We integrated spatially addressable hydrogel biomaterial platforms, patient site-directed biopsies, and multiomics analyses to define metabolic drivers of invasive glioblastoma cells. Metabolomics and lipidomics revealed elevations in the redox buffers cystathionine, hexosylceramides, and glucosyl ceramides in the invasive front of both hydrogel-cultured tumors and patient site-directed biopsies, with immunofluorescence indicating elevated reactive oxygen species (ROS) markers in invasive cells. Transcriptomics confirmed upregulation of ROS-producing and response genes at the invasive front in both hydrogel models and patient tumors. Among oncologic ROS, H2O2 specifically promoted glioblastoma invasion in 3D hydrogel spheroid cultures. A CRISPR metabolic gene screen revealed cystathionine γ-lyase (CTH), which converts cystathionine to the nonessential amino acid cysteine in the transsulfuration pathway, to be essential for glioblastoma invasion. Correspondingly, supplementing CTH knockdown cells with exogenous cysteine rescued invasion. Pharmacologic CTH inhibition suppressed glioblastoma invasion, while CTH knockdown slowed glioblastoma invasion in vivo. Our studies highlight the importance of ROS metabolism in invasive glioblastoma cells and support further exploration of the transsulfuration pathway as a mechanistic and therapeutic target.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma Limite: Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma Limite: Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2023 Tipo de documento: Article